Advertisement

Topics

Endo unit cleared of liability in first testosterone replacement trial

16:21 EST 17 Nov 2017 | Topix

NEW YORK: A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim. The verdict was a victory for the drugmaker in its first trial over allegations it defectively designed Testim, a skin gel, and negligently misrepresented its risks.

Original Article: Endo unit cleared of liability in first testosterone replacement trial

NEXT ARTICLE

More From BioPortfolio on "Endo unit cleared of liability in first testosterone replacement trial"

Advertisement
Quick Search
Advertisement
Advertisement